Diabetes practices emerge from the COVID-19 pandemic 

Rely on Atellica DCA Analyzer to optimize your in-office POC diabetes testing

With many point-of-care HbA1c testing facilities closing their doors due to the COVID-19 pandemic, many people living with diabetes were unable to have their HbA1c tested. A full year of uncontrolled diabetes is not benign and could affect life expectancy.1 Let’s get patients back to the point of care and provide important HbA1c testing.

Point-of-care testing has proven more effective in reducing HbA1c than other testing methods. Face-to-face counseling enables education, helps to engage patients, and leads to increased compliance.

Click here to explore how Atellica DCA Analyzer2 can help you optimize your point-of-care HbA1c testing